Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)
2 other identifiers
interventional
19
1 country
1
Brief Summary
Investigating modulation of motor cortex excitability by transcranial magnetic stimulation and transcranial direct current stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedStudy Start
First participant enrolled
August 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedResults Posted
Study results publicly available
October 23, 2019
CompletedMarch 4, 2021
February 1, 2021
5 months
March 9, 2018
September 11, 2019
February 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in Motor-evoked Potentials Ratios
The investigators will record motor-evoked potentials and calculate changes in between before and after 2mA tDCS stimulation for 10 minutes.
right before and after 2mA tDCS stimulation for 10 minutes at each session
Changes in TMS-evoked Potentials Ratios
The investigators will record TMS-evoked potentials using EEG and calculate changes in between before and after 2mA tDCS stimulation for 10 minutes.
right before and after 2mA tDCS stimulation for 10 minutes at each session
Secondary Outcomes (1)
Changes in Resting-state EEG Dynamics Ratios
4 minutes recordings before and after each 2mA tDCS stimulation for 10 minutes at each session
Study Arms (3)
anodal tDCS
ACTIVE COMPARATORTwo electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex). This anodal tDCS on the left motor cortex will be stimulated with 2mA for 10 minutes.
cathodal tDCS
ACTIVE COMPARATORTwo electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex). This cathodal tDCS on the left motor cortex will be stimulated with -2mA for 10 minutes.
sham tDCS
SHAM COMPARATORTwo electrodes will be applied to the scalp (one on the left motor cortex, one on the right supraorbital cortex). Sham stimulation with 2mA for 40 seconds will be applied.
Interventions
The participant will receive anodal tDCS with 2 mA for 10 minutes on the left motor cortex.
The participant will receive cathodal tDCS with -2 mA for 10 minutes on the left motor cortex.
The participant will receive sham tDCS with 2 mA for 40 seconds on the left motor cortex which mimics the skin sensations as active tDCS interventions.
Eligibility Criteria
You may qualify if:
- Male
- Between the ages of 18 and 35
- Right-handed
- Capacity to understand all relevant risks and potential benefits of the study (informed consent)
- Willing to comply with all study procedures and be available for the duration of the study
- Speak and understand English
You may not qualify if:
- Prior concussion
- Diagnosis of eating disorder (current or within the past 6 months)
- Diagnosis of obsessive compulsive disorder (lifetime)
- Attention-deficit/hyperactivity disorder (currently under treatment)
- Neurological disorders and conditions, including, but not limited to:
- History of epilepsy
- Seizures (except childhood febrile seizures and electroconvulsive therapy-induced seizures)
- Dementia
- History of stroke
- Parkinson's disease
- Multiple sclerosis
- Cerebral aneurysm
- Brain tumors
- Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment)
- Prior brain surgery
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Sangtae Ahn
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Flavio Frohlich, PhD
University of North Carolina at Chapel Hill - Department of Psychiatry
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- This is a double-blind and cross-over study.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2018
First Posted
March 29, 2018
Study Start
August 24, 2018
Primary Completion
January 31, 2019
Study Completion
February 1, 2019
Last Updated
March 4, 2021
Results First Posted
October 23, 2019
Record last verified: 2021-02